Emerging Research: Mitochondrial Uncouplers As Promising Obesity Treatments
Obesity now affects over 650 million adults worldwide, with rates continuing to climb. Associated metabolic disorders like non-alcoholic fatty liver disease (NAFLD), type 2 diabetes, and cardiovascular disease have reached epidemic proportions, now posing some of the greatest threats to public health. While diet and lifestyle changes remain the cornerstone of treatment, adherence to these interventions long-term is extremely challenging, with most people regaining lost weight. There is an urgent need for novel, safe pharmaceuticals to help combat obesity and related metabolic complications. One exciting area of research is investigating whether compounds that alter cellular energy metabolism could ramp up…